C-terminal modification of polypeptides

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8927230
SERIAL NO

13741206

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to a mutated trypsin comprising an amino acid substitution both at position K60 and D189, and at least one more amino acid substitution by histidine at position N143 or position E151. Such trypsin mutant has a preferred cleavage site comprising the amino acids Xaa1-Xaa2-His, wherein Xaa1 is L, Y or F and Xaa2 is R or K. The invention also relates to a man-made polypeptide comprising a target peptide and the above cleavage site as well as to a method of producing C-terminally modified target peptides by using this mutated trypsin.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
EUCODIS BIOSCIENCE GMBH1030 WIEN

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bordusa, Frank Rossbach, DE 6 13
Hermann, Rupert Weilheim, DE 7 21
Hoess, Eva Neuried, DE 23 155
Jakubke, Hans-Dieter Dresden-Langebrueck, DE 7 49
Tischer, Wilhelm Peissenberg, DE 19 173

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 6, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00